Skip to content
← Childhood Acute Myeloid Leukemia

FOR PATIENTS · SOURCE READING

Key Points

Source: Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: June 5, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Option Overview

There are different types of treatment for children with acute myeloid leukemia and other myeloid malignancies.

Treatment is planned by a team of health care providers who are experts in treating childhood leukemia and other diseases of the blood.

The treatment of childhood AML and other myeloid malignancies usually has two phases.

Seven types of standard treatment may be used for childhood AML and other myeloid malignancies.

Seven types of standard treatment may be used for childhood AML and other myeloid malignancies.

Chemotherapy

Seven types of standard treatment may be used for childhood AML and other myeloid malignancies.

Radiation therapy

Seven types of standard treatment may be used for childhood AML and other myeloid malignancies.

Stem cell transplant

Seven types of standard treatment may be used for childhood AML and other myeloid malignancies.

Targeted therapy

Seven types of standard treatment may be used for childhood AML and other myeloid malignancies.

Other drug therapy

Seven types of standard treatment may be used for childhood AML and other myeloid malignancies.

Watchful waiting

Seven types of standard treatment may be used for childhood AML and other myeloid malignancies.

Supportive care

New types of treatment are being tested in clinical trials.

Treatment for childhood acute myeloid leukemia and other myeloid malignancies may cause side effects.

Patients may want to think about taking part in a clinical trial.

Patients can enter clinical trials before, during, or after starting their cancer treatment.

Follow-up tests may be needed.

Preserved source evidence · Independent clinical review pending · Not medical advice